Hospitality segments boost property developments: UOBKayHian

City Developments Limited and Capitaland Investment reported strong results.

City Developments Limited and Capitaland Investment posted strong growth, driven by their lodging and hospitality sector, said UOBKayHian.

CLI’s ambitions in funds management are expected to pay off this year whilst CDL focuses on Singapore and the UK business.

CapitaLand Investment (CLI) reported a strong set of results with core PATMI up 23% yoy due to better performance in its Fee Income-related Businesses (FRB) and recovery in its lodging business.

But EBITDA was 10% lower year-on-year, the post-COVID-19 reflation story is expected to positively impact contributions from China this year.

CDL retains its goal for expansion in the living sector with its UK segment comprising 5% of its total assets or about $1b.

The broker retained its buy rating for both of the property developers.

Follow the links for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare